COVID‐19 and the Emerging Regulatory Guidance for Ongoing Clinical Trials in the European Union

The coronavirus disease 2019 (COVID‐19) pandemic and the accompanying control measures have significantly affected clinical trial (CT) conduct, and sponsors have needed to make rapid changes to their CT operations. As a result, regulatory guidance was pivotal during the initial phases of the pandemi...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Amos Jochanan, Santa‐Ana‐Tellez, Yared, van Thiel, Ghislaine José Madeleine Wilhelmien, Zuidgeest, Mira Gerta Petra, Siiskonen, Satu Johanna, Mistry, Dinesh, de Boer, Anthonius, Gardarsdottir, Helga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013428/
https://www.ncbi.nlm.nih.gov/pubmed/33666223
http://dx.doi.org/10.1002/cpt.2225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013428/
https://www.ncbi.nlm.nih.gov/pubmed/33666223
http://dx.doi.org/10.1002/cpt.2225

Ejemplares similares